Vullierme Marie-Pierre, Giraud-Cohen Marie, Hammel Pascal, Sauvanet Alain, Couvelard Anne, O'Toole Dermot, Levy Philippe, Ruszniewski Philippe, Vilgrain Valérie
Department of Radiology, Beaujon Hospital, Clichy La Garenne, France.
Radiology. 2007 Nov;245(2):483-90. doi: 10.1148/radiol.2451060951. Epub 2007 Sep 11.
To retrospectively evaluate computed tomographic (CT) findings in patients with in situ and invasive malignant intraductal papillary mucinous neoplasms (IPMNs) of the pancreas and to evaluate the accuracy for surgical resectability, with surgery and pathologic analysis as the reference standards.
Institutional review board approval was obtained, and the informed consent requirement was waived. Forty-six patients with malignant IPMN proved at pathologic examination of the surgically resected specimen (n = 44) or laparotomy (n = 2) underwent surgery after multidetector CT was performed. CT findings were retrospectively evaluated to determine if a pancreatic malignant IPMN tumor was present; to make this determination, CT criteria were used to differentiate in situ from invasive tumors and signs of unresectability (liver metastasis, vascular CT pattern of encasement, or regional lymph node metastasis). The extent of the vascular CT pattern of encasement was recorded for each patient (no obliteration of the fat plane, obliteration of the fat plane of <50%, or obliteration of the fat plane of > or =50%). Statistical analysis was performed with the chi(2) and Student t tests.
CT revealed a mural nodule in the pancreatic duct wall in 14 patients with in situ carcinoma and one patient with invasive carcinoma (P < .003). CT revealed an infiltrative pancreatic mass in 17 patients with invasive carcinoma and two patients with in situ carcinoma (P < .02). Of the mural nodules, 93% were seen in patients with in situ carcinoma, whereas 90% of infiltrative pancreatic masses were observed in patients with invasive carcinomas. The positive predictive value of CT for determining resectability was 100%, and the overall accuracy of CT for determining resectability and unresectability was 74%. The positive predictive value of CT for determining unresectability was 17%, mainly owing to overestimation of arterial invasion.
CT is helpful in the differentiation of in situ and invasive IPMN. Classic vascular invasion criteria lead to the overestimation of surgical tumor unresectability in patients with malignant IPMN.
回顾性评估胰腺原位和浸润性恶性导管内乳头状黏液性肿瘤(IPMN)患者的计算机断层扫描(CT)表现,并以手术和病理分析作为参考标准,评估其对手术可切除性的诊断准确性。
获得机构审查委员会批准,并豁免知情同意要求。46例经手术切除标本(n = 44)或剖腹手术(n = 2)病理检查证实为恶性IPMN的患者在进行多排CT检查后接受了手术。回顾性评估CT表现,以确定是否存在胰腺恶性IPMN肿瘤;为做出这一判断,使用CT标准区分原位肿瘤与浸润性肿瘤以及不可切除的征象(肝转移、血管CT包绕模式或区域淋巴结转移)。记录每位患者血管CT包绕模式的范围(脂肪平面无闭塞、脂肪平面闭塞<50%或脂肪平面闭塞≥50%)。采用卡方检验和学生t检验进行统计分析。
CT显示14例原位癌患者和1例浸润癌患者的胰管壁有壁结节(P <.003)。CT显示17例浸润癌患者和2例原位癌患者有浸润性胰腺肿块(P <.02)。在壁结节中,93%见于原位癌患者,而90%的浸润性胰腺肿块见于浸润癌患者。CT判断可切除性的阳性预测值为100%,CT判断可切除性和不可切除性的总体准确性为74%。CT判断不可切除性的阳性预测值为17%,主要是由于对动脉侵犯的高估。
CT有助于区分原位和浸润性IPMN。经典的血管侵犯标准导致对恶性IPMN患者手术肿瘤不可切除性的高估。